Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Furosemide for Post-Operative Sinonasal Polyposis
NCT03362515Phase 2Terminated
- Sponsor
- Thomas Jefferson University
- Start
- Dec 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in nasal polyps, sponsored by Thomas Jefferson University. Started Dec 2017; status: terminated.
02
Drugs
furosemide
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT03362515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362515.